Clinical Trial in CD

cultivate-logo

Enrolling Soon

Addressing the root of CD

Etrasimod is an investigational, once-daily, oral S1P receptor modulator designed to selectively target S1P1, S1P4, and S1P5, with no observed activity for S1P2 and S1P3 at therapeutic doses.